nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—Platinum-containing Compounds—Cisplatin—testicular cancer	0.312	0.512	CiPCiCtD
Oxaliplatin—Platinum-containing Compounds—Carboplatin—testicular cancer	0.297	0.488	CiPCiCtD
Oxaliplatin—GSTP1—Chlorambucil—testicular cancer	0.0255	0.0702	CbGbCtD
Oxaliplatin—ATP7B—Carboplatin—testicular cancer	0.0198	0.0546	CbGbCtD
Oxaliplatin—MT1A—Carboplatin—testicular cancer	0.0198	0.0546	CbGbCtD
Oxaliplatin—MT2A—Carboplatin—testicular cancer	0.0198	0.0546	CbGbCtD
Oxaliplatin—ATP7A—Carboplatin—testicular cancer	0.0198	0.0546	CbGbCtD
Oxaliplatin—MT1A—Cisplatin—testicular cancer	0.0169	0.0467	CbGbCtD
Oxaliplatin—MT2A—Cisplatin—testicular cancer	0.0169	0.0467	CbGbCtD
Oxaliplatin—ATP7A—Cisplatin—testicular cancer	0.0169	0.0467	CbGbCtD
Oxaliplatin—ATP7B—Cisplatin—testicular cancer	0.0169	0.0467	CbGbCtD
Oxaliplatin—SLC31A1—Carboplatin—testicular cancer	0.0157	0.0434	CbGbCtD
Oxaliplatin—SOD1—Carboplatin—testicular cancer	0.0157	0.0434	CbGbCtD
Oxaliplatin—SLC31A1—Cisplatin—testicular cancer	0.0134	0.0371	CbGbCtD
Oxaliplatin—SOD1—Cisplatin—testicular cancer	0.0134	0.0371	CbGbCtD
Oxaliplatin—GSTT1—Carboplatin—testicular cancer	0.0132	0.0363	CbGbCtD
Oxaliplatin—GSTM1—Carboplatin—testicular cancer	0.0114	0.0314	CbGbCtD
Oxaliplatin—GSTT1—Cisplatin—testicular cancer	0.0112	0.031	CbGbCtD
Oxaliplatin—GSTT1—Etoposide—testicular cancer	0.011	0.0305	CbGbCtD
Oxaliplatin—GSTM1—Cisplatin—testicular cancer	0.00971	0.0268	CbGbCtD
Oxaliplatin—NQO1—Carboplatin—testicular cancer	0.00903	0.0249	CbGbCtD
Oxaliplatin—GSTP1—Carboplatin—testicular cancer	0.00822	0.0227	CbGbCtD
Oxaliplatin—NQO1—Cisplatin—testicular cancer	0.00772	0.0213	CbGbCtD
Oxaliplatin—GSTP1—Cisplatin—testicular cancer	0.00702	0.0194	CbGbCtD
Oxaliplatin—GSTP1—Etoposide—testicular cancer	0.0069	0.019	CbGbCtD
Oxaliplatin—NQO1—Doxorubicin—testicular cancer	0.00517	0.0143	CbGbCtD
Oxaliplatin—MPO—Carboplatin—testicular cancer	0.00472	0.013	CbGbCtD
Oxaliplatin—MPO—Cisplatin—testicular cancer	0.00403	0.0111	CbGbCtD
Oxaliplatin—ABCG2—Dactinomycin—testicular cancer	0.00222	0.00612	CbGbCtD
Oxaliplatin—SLC22A2—Vinblastine—testicular cancer	0.00188	0.00519	CbGbCtD
Oxaliplatin—CYP1B1—Doxorubicin—testicular cancer	0.0018	0.00496	CbGbCtD
Oxaliplatin—SLC22A2—Cisplatin—testicular cancer	0.00173	0.00476	CbGbCtD
Oxaliplatin—ABCC2—Carboplatin—testicular cancer	0.00165	0.00455	CbGbCtD
Oxaliplatin—ABCC2—Vinblastine—testicular cancer	0.00154	0.00424	CbGbCtD
Oxaliplatin—ABCG2—Carboplatin—testicular cancer	0.00149	0.00411	CbGbCtD
Oxaliplatin—ABCC2—Cisplatin—testicular cancer	0.00141	0.00389	CbGbCtD
Oxaliplatin—ABCC2—Etoposide—testicular cancer	0.00138	0.00382	CbGbCtD
Oxaliplatin—ABCG2—Cisplatin—testicular cancer	0.00127	0.00352	CbGbCtD
Oxaliplatin—ABCG2—Etoposide—testicular cancer	0.00125	0.00345	CbGbCtD
Oxaliplatin—ABCC2—Doxorubicin—testicular cancer	0.000945	0.00261	CbGbCtD
Oxaliplatin—ABCC2—Methotrexate—testicular cancer	0.000915	0.00252	CbGbCtD
Oxaliplatin—CYP2E1—Etoposide—testicular cancer	0.000893	0.00246	CbGbCtD
Oxaliplatin—SLC31A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000856	0.0771	CbGpPWpGaD
Oxaliplatin—ABCG2—Doxorubicin—testicular cancer	0.000854	0.00236	CbGbCtD
Oxaliplatin—ABCG2—Methotrexate—testicular cancer	0.000827	0.00228	CbGbCtD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—TFAP2C—testicular cancer	0.000799	0.072	CbGpPWpGaD
Oxaliplatin—NQO1—Vincristine—Vinblastine—testicular cancer	0.000781	1	CbGdCrCtD
Oxaliplatin—GSTT1—Glutathione conjugation—HPGDS—testicular cancer	0.000755	0.068	CbGpPWpGaD
Oxaliplatin—ATP7A—seminal vesicle—testicular cancer	0.000693	0.0413	CbGeAlD
Oxaliplatin—SOD1—seminal vesicle—testicular cancer	0.000607	0.0361	CbGeAlD
Oxaliplatin—SLC31A1—seminal vesicle—testicular cancer	0.000591	0.0352	CbGeAlD
Oxaliplatin—MT2A—gonad—testicular cancer	0.000578	0.0345	CbGeAlD
Oxaliplatin—CYP1A2—Etoposide—testicular cancer	0.000516	0.00142	CbGbCtD
Oxaliplatin—ATP7B—female gonad—testicular cancer	0.000506	0.0301	CbGeAlD
Oxaliplatin—MT1A—testis—testicular cancer	0.000501	0.0298	CbGeAlD
Oxaliplatin—GSTM1—Glutathione conjugation—HPGDS—testicular cancer	0.000486	0.0438	CbGpPWpGaD
Oxaliplatin—MT2A—female gonad—testicular cancer	0.00047	0.028	CbGeAlD
Oxaliplatin—ATP7B—testis—testicular cancer	0.000448	0.0267	CbGeAlD
Oxaliplatin—SLC31A1—gonad—testicular cancer	0.000427	0.0255	CbGeAlD
Oxaliplatin—GSTM1—gonad—testicular cancer	0.000417	0.0248	CbGeAlD
Oxaliplatin—MT2A—testis—testicular cancer	0.000417	0.0248	CbGeAlD
Oxaliplatin—GSTP1—Glutathione conjugation—HPGDS—testicular cancer	0.000414	0.0373	CbGpPWpGaD
Oxaliplatin—ATP7A—female gonad—testicular cancer	0.000407	0.0243	CbGeAlD
Oxaliplatin—NQO1—seminal vesicle—testicular cancer	0.000404	0.0241	CbGeAlD
Oxaliplatin—GSTM1—NRF2 pathway—SLC2A6—testicular cancer	0.000398	0.0358	CbGpPWpGaD
Oxaliplatin—SLC31A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000389	0.0351	CbGpPWpGaD
Oxaliplatin—GSTP1—embryo—testicular cancer	0.000385	0.0229	CbGeAlD
Oxaliplatin—MT1A—lymph node—testicular cancer	0.000363	0.0216	CbGeAlD
Oxaliplatin—GSTP1—seminal vesicle—testicular cancer	0.000361	0.0215	CbGeAlD
Oxaliplatin—ATP7A—testis—testicular cancer	0.000361	0.0215	CbGeAlD
Oxaliplatin—SOD1—female gonad—testicular cancer	0.000356	0.0212	CbGeAlD
Oxaliplatin—SLC31A1—female gonad—testicular cancer	0.000347	0.0207	CbGeAlD
Oxaliplatin—GSTM1—female gonad—testicular cancer	0.000339	0.0202	CbGeAlD
Oxaliplatin—GSTP1—NRF2 pathway—SLC2A6—testicular cancer	0.000338	0.0305	CbGpPWpGaD
Oxaliplatin—GSTT1—Phase II conjugation—HPGDS—testicular cancer	0.000336	0.0303	CbGpPWpGaD
Oxaliplatin—NQO1—NRF2 pathway—SLC2A6—testicular cancer	0.00033	0.0297	CbGpPWpGaD
Oxaliplatin—SLC22A3—embryo—testicular cancer	0.000329	0.0196	CbGeAlD
Oxaliplatin—ATP7B—lymph node—testicular cancer	0.000325	0.0194	CbGeAlD
Oxaliplatin—SOD1—testis—testicular cancer	0.000316	0.0188	CbGeAlD
Oxaliplatin—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000315	0.0284	CbGpPWpGaD
Oxaliplatin—SLC22A3—seminal vesicle—testicular cancer	0.000309	0.0184	CbGeAlD
Oxaliplatin—SLC31A1—testis—testicular cancer	0.000308	0.0183	CbGeAlD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000301	0.0272	CbGpPWpGaD
Oxaliplatin—GSTM1—testis—testicular cancer	0.000301	0.0179	CbGeAlD
Oxaliplatin—CA4—seminal vesicle—testicular cancer	0.000275	0.0164	CbGeAlD
Oxaliplatin—ATP7A—lymph node—testicular cancer	0.000262	0.0156	CbGeAlD
Oxaliplatin—GSTP1—gonad—testicular cancer	0.000261	0.0156	CbGeAlD
Oxaliplatin—ATP7B—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000243	0.0219	CbGpPWpGaD
Oxaliplatin—NQO1—female gonad—testicular cancer	0.000238	0.0142	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000236	0.0212	CbGpPWpGaD
Oxaliplatin—SOD1—lymph node—testicular cancer	0.000229	0.0136	CbGeAlD
Oxaliplatin—SLC22A3—gonad—testicular cancer	0.000223	0.0133	CbGeAlD
Oxaliplatin—SLC31A1—lymph node—testicular cancer	0.000223	0.0133	CbGeAlD
Oxaliplatin—GSTM1—lymph node—testicular cancer	0.000218	0.013	CbGeAlD
Oxaliplatin—GSTM1—Phase II conjugation—HPGDS—testicular cancer	0.000217	0.0195	CbGpPWpGaD
Oxaliplatin—GSTP1—female gonad—testicular cancer	0.000212	0.0126	CbGeAlD
Oxaliplatin—ABCG2—seminal vesicle—testicular cancer	0.000212	0.0126	CbGeAlD
Oxaliplatin—NQO1—testis—testicular cancer	0.000211	0.0126	CbGeAlD
Oxaliplatin—ATP7A—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000206	0.0186	CbGpPWpGaD
Oxaliplatin—CYP1B1—gonad—testicular cancer	0.000205	0.0122	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—MAD1L1—testicular cancer	0.0002	0.018	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000198	0.0178	CbGpPWpGaD
Oxaliplatin—SLC31A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000198	0.0178	CbGpPWpGaD
Oxaliplatin—GSTT1—Biological oxidations—HPGDS—testicular cancer	0.000197	0.0177	CbGpPWpGaD
Oxaliplatin—MPO—testis—testicular cancer	0.000194	0.0115	CbGeAlD
Oxaliplatin—GSTP1—testis—testicular cancer	0.000188	0.0112	CbGeAlD
Oxaliplatin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000184	0.0166	CbGpPWpGaD
Oxaliplatin—GSTP1—Phase II conjugation—HPGDS—testicular cancer	0.000184	0.0166	CbGpPWpGaD
Oxaliplatin—CYP2E1—seminal vesicle—testicular cancer	0.000183	0.0109	CbGeAlD
Oxaliplatin—SLC22A3—female gonad—testicular cancer	0.000181	0.0108	CbGeAlD
Oxaliplatin—CYP1B1—female gonad—testicular cancer	0.000167	0.00994	CbGeAlD
Oxaliplatin—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000166	0.0149	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000164	0.0148	CbGpPWpGaD
Oxaliplatin—CA4—female gonad—testicular cancer	0.000162	0.00964	CbGeAlD
Oxaliplatin—SLC22A3—testis—testicular cancer	0.000161	0.00959	CbGeAlD
Oxaliplatin—NQO1—lymph node—testicular cancer	0.000153	0.0091	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—KITLG—testicular cancer	0.000151	0.0136	CbGpPWpGaD
Oxaliplatin—ABCC2—testis—testicular cancer	0.000151	0.009	CbGeAlD
Oxaliplatin—CYP1B1—testis—testicular cancer	0.000148	0.00881	CbGeAlD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000145	0.013	CbGpPWpGaD
Oxaliplatin—CA4—testis—testicular cancer	0.000143	0.00855	CbGeAlD
Oxaliplatin—SLC22A3—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000143	0.0129	CbGpPWpGaD
Oxaliplatin—MPO—lymph node—testicular cancer	0.00014	0.00836	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—H2AFZ—testicular cancer	0.00014	0.0126	CbGpPWpGaD
Oxaliplatin—GSTP1—lymph node—testicular cancer	0.000136	0.00813	CbGeAlD
Oxaliplatin—CYP1B1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000135	0.0122	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—KITLG—testicular cancer	0.000128	0.0116	CbGpPWpGaD
Oxaliplatin—GSTM1—Biological oxidations—HPGDS—testicular cancer	0.000127	0.0114	CbGpPWpGaD
Oxaliplatin—ABCG2—female gonad—testicular cancer	0.000124	0.0074	CbGeAlD
Oxaliplatin—CYP1A1—female gonad—testicular cancer	0.000118	0.00703	CbGeAlD
Oxaliplatin—SLC22A3—lymph node—testicular cancer	0.000117	0.00695	CbGeAlD
Oxaliplatin—ABCG2—testis—testicular cancer	0.00011	0.00656	CbGeAlD
Oxaliplatin—ABCC2—lymph node—testicular cancer	0.000109	0.00652	CbGeAlD
Oxaliplatin—SOD1—AGE/RAGE pathway—MMP2—testicular cancer	0.000108	0.00973	CbGpPWpGaD
Oxaliplatin—GSTP1—Biological oxidations—HPGDS—testicular cancer	0.000108	0.0097	CbGpPWpGaD
Oxaliplatin—CYP1B1—lymph node—testicular cancer	0.000107	0.00639	CbGeAlD
Oxaliplatin—ATP7A—Cellular responses to stress—H2AFZ—testicular cancer	0.000106	0.00958	CbGpPWpGaD
Oxaliplatin—CA4—lymph node—testicular cancer	0.000104	0.0062	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—KIT—testicular cancer	0.000103	0.00929	CbGpPWpGaD
Oxaliplatin—CYP2E1—testis—testicular cancer	9.54e-05	0.00568	CbGeAlD
Oxaliplatin—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	8.99e-05	0.0081	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	8.92e-05	0.00803	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—KIT—testicular cancer	8.77e-05	0.0079	CbGpPWpGaD
Oxaliplatin—SLC22A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	8.38e-05	0.00755	CbGpPWpGaD
Oxaliplatin—CYP1A1—Arachidonic acid metabolism—HPGDS—testicular cancer	8.34e-05	0.00752	CbGpPWpGaD
Oxaliplatin—ABCG2—lymph node—testicular cancer	7.99e-05	0.00476	CbGeAlD
Oxaliplatin—CYP1A1—lymph node—testicular cancer	7.58e-05	0.00452	CbGeAlD
Oxaliplatin—SLC22A3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.28e-05	0.00656	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—H2AFZ—testicular cancer	6.4e-05	0.00577	CbGpPWpGaD
Oxaliplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	5.75e-05	0.00518	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	5.69e-05	0.00512	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—H2AFZ—testicular cancer	5.59e-05	0.00503	CbGpPWpGaD
Oxaliplatin—CYP1A2—Arachidonic acid metabolism—HPGDS—testicular cancer	5.32e-05	0.00479	CbGpPWpGaD
Oxaliplatin—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	5.31e-05	0.00478	CbGpPWpGaD
Oxaliplatin—CYP1B1—Biological oxidations—HPGDS—testicular cancer	5.04e-05	0.00454	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—BCL10—testicular cancer	4.75e-05	0.00428	CbGpPWpGaD
Oxaliplatin—ABCG2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.62e-05	0.00416	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.57e-05	0.00411	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	4.26e-05	0.00383	CbGpPWpGaD
Oxaliplatin—CYP1A2—Phase II conjugation—HPGDS—testicular cancer	3.38e-05	0.00305	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—HPGDS—testicular cancer	3.36e-05	0.00303	CbGpPWpGaD
Oxaliplatin—CYP2E1—Biological oxidations—HPGDS—testicular cancer	3.29e-05	0.00297	CbGpPWpGaD
Oxaliplatin—CYP1A1—Biological oxidations—HPGDS—testicular cancer	3.11e-05	0.0028	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—KITLG—testicular cancer	2.87e-05	0.00258	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—STK11—testicular cancer	2.44e-05	0.0022	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—HPGDS—testicular cancer	2.17e-05	0.00195	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—FGFR3—testicular cancer	2.13e-05	0.00192	CbGpPWpGaD
Oxaliplatin—CYP1A2—Biological oxidations—HPGDS—testicular cancer	1.98e-05	0.00178	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—KIT—testicular cancer	1.96e-05	0.00176	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.94e-05	0.00174	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—HPGDS—testicular cancer	1.92e-05	0.00173	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—HPGDS—testicular cancer	1.84e-05	0.00166	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—HPGDS—testicular cancer	1.8e-05	0.00162	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—STK11—testicular cancer	1.57e-05	0.00142	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—STK11—testicular cancer	1.4e-05	0.00126	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—STK11—testicular cancer	1.34e-05	0.00121	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—STK11—testicular cancer	1.3e-05	0.00117	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—HPGDS—testicular cancer	1.24e-05	0.00112	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	1.19e-05	0.00107	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—STK11—testicular cancer	9e-06	0.00081	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—HPGDS—testicular cancer	8.62e-06	0.000777	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—HPGDS—testicular cancer	7.85e-06	0.000707	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—HPGDS—testicular cancer	7.77e-06	0.000699	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.6e-06	0.000685	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—HPGDS—testicular cancer	7.24e-06	0.000652	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—STK11—testicular cancer	6.27e-06	0.000564	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—STK11—testicular cancer	5.7e-06	0.000513	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—STK11—testicular cancer	5.64e-06	0.000508	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—HPGDS—testicular cancer	5.63e-06	0.000507	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—HPGDS—testicular cancer	5.31e-06	0.000478	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—STK11—testicular cancer	5.26e-06	0.000474	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—STK11—testicular cancer	4.09e-06	0.000369	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—STK11—testicular cancer	3.86e-06	0.000348	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—HPGDS—testicular cancer	3.39e-06	0.000305	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—STK11—testicular cancer	2.46e-06	0.000222	CbGpPWpGaD
